Jennifer Amengual – New Associate Editor for Blood Neoplasia!
Blood Journals Portfolio shared on LinkedIn:
”We are delighted to introduce Dr. Jennifer Amengual, new Associate Editor for Blood Neoplasia!
Dr. Amengual is an Associate Professor of Medicine at Columbia University Irving Medical Center and a physician-scientist whose research focuses on developing targeted therapies for patients with lymphoma.
Her work has advanced our understanding of epigenetic and transcriptional pathways in germinal center–derived B-cell and T-cell lymphomas, as well as strategies to predict, prevent, and treat post-transplant lymphoproliferative disorders.
Beyond her research, Dr. Amengual is a dedicated mentor and an active member of American Society of Hematology, contributing to programs such as CRTI, TRTH, and the Hematology Review Series.
She has also led impactful clinical trials through ETCTN/CTEP, SWOG, and investigator-initiated studies.
Please join us in welcoming Dr. Amengual to the Blood Neoplasia team.”
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients